Cigna Competitors

Cigna (NYSE:CI) and Bank of America (NYSE:BAC) are both large-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Institutional and Insider Ownership

87.1% of Cigna shares are held by institutional investors. Comparatively, 68.1% of Bank of America shares are held by institutional investors. 0.9% of Cigna shares are held by company insiders. Comparatively, 0.2% of Bank of America shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations for Cigna and Bank of America, as reported by MarketBeat.com.

Cigna currently has a consensus target price of $248.40, suggesting a potential upside of 7.71%. Bank of America has a consensus target price of $33.1842, suggesting a potential downside of 10.14%. Given Cigna's stronger consensus rating and higher probable upside, research analysts clearly believe Cigna is more favorable than Bank of America.

Profitability

This table compares Cigna and Bank of America's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Cigna and Bank of America's gross revenue, earnings per share (EPS) and valuation.

Bank of America has lower revenue, but higher earnings than Cigna. Bank of America is trading at a lower price-to-earnings ratio than Cigna, indicating that it is currently the more affordable of the two stocks.

Dividends

Cigna pays an annual dividend of $0.04 per share and has a dividend yield of 0.0%. Bank of America pays an annual dividend of $0.72 per share and has a dividend yield of 1.9%. Cigna pays out 0.2% of its earnings in the form of a dividend. Bank of America pays out 24.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna has raised its dividend for 1 consecutive years and Bank of America has raised its dividend for 1 consecutive years.

Risk & Volatility

Cigna has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, Bank of America has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500.

Summary

Cigna beats Bank of America on 10 of the 17 factors compared between the two stocks.

Wells Fargo & Company (NYSE:WFC) and Cigna (NYSE:CI) are both large-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.

Dividends

Wells Fargo & Company pays an annual dividend of $0.40 per share and has a dividend yield of 1.1%. Cigna pays an annual dividend of $0.04 per share and has a dividend yield of 0.0%. Wells Fargo & Company pays out 9.1% of its earnings in the form of a dividend. Cigna pays out 0.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Wells Fargo & Company has increased its dividend for 1 consecutive years and Cigna has increased its dividend for 1 consecutive years.

Profitability

This table compares Wells Fargo & Company and Cigna's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings for Wells Fargo & Company and Cigna, as provided by MarketBeat.com.

Wells Fargo & Company currently has a consensus price target of $33.7826, suggesting a potential downside of 9.74%. Cigna has a consensus price target of $248.40, suggesting a potential upside of 7.71%. Given Cigna's stronger consensus rating and higher probable upside, analysts clearly believe Cigna is more favorable than Wells Fargo & Company.

Institutional and Insider Ownership

67.3% of Wells Fargo & Company shares are owned by institutional investors. Comparatively, 87.1% of Cigna shares are owned by institutional investors. 0.1% of Wells Fargo & Company shares are owned by company insiders. Comparatively, 0.9% of Cigna shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Wells Fargo & Company and Cigna's revenue, earnings per share (EPS) and valuation.

Wells Fargo & Company has higher earnings, but lower revenue than Cigna. Wells Fargo & Company is trading at a lower price-to-earnings ratio than Cigna, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Wells Fargo & Company has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Comparatively, Cigna has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500.

Summary

Cigna beats Wells Fargo & Company on 10 of the 17 factors compared between the two stocks.

HDFC Bank (NYSE:HDB) and Cigna (NYSE:CI) are both large-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations.

Profitability

This table compares HDFC Bank and Cigna's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current recommendations and price targets for HDFC Bank and Cigna, as provided by MarketBeat.com.

Cigna has a consensus price target of $248.40, indicating a potential upside of 7.71%. Given Cigna's stronger consensus rating and higher probable upside, analysts plainly believe Cigna is more favorable than HDFC Bank.

Institutional & Insider Ownership

17.8% of HDFC Bank shares are held by institutional investors. Comparatively, 87.1% of Cigna shares are held by institutional investors. 1.0% of HDFC Bank shares are held by company insiders. Comparatively, 0.9% of Cigna shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares HDFC Bank and Cigna's gross revenue, earnings per share (EPS) and valuation.

Cigna has higher revenue and earnings than HDFC Bank. Cigna is trading at a lower price-to-earnings ratio than HDFC Bank, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

HDFC Bank has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Cigna has a beta of 0.88, indicating that its stock price is 12% less volatile than the S&P 500.

Summary

Cigna beats HDFC Bank on 9 of the 15 factors compared between the two stocks.

Citigroup (NYSE:C) and Cigna (NYSE:CI) are both large-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations.

Dividends

Citigroup pays an annual dividend of $2.04 per share and has a dividend yield of 2.9%. Cigna pays an annual dividend of $0.04 per share and has a dividend yield of 0.0%. Citigroup pays out 41.8% of its earnings in the form of a dividend. Cigna pays out 0.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Citigroup has raised its dividend for 1 consecutive years and Cigna has raised its dividend for 1 consecutive years.

Profitability

This table compares Citigroup and Cigna's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current recommendations and price targets for Citigroup and Cigna, as provided by MarketBeat.com.

Citigroup presently has a consensus price target of $71.8750, indicating a potential upside of 2.34%. Cigna has a consensus price target of $248.40, indicating a potential upside of 7.71%. Given Cigna's stronger consensus rating and higher probable upside, analysts plainly believe Cigna is more favorable than Citigroup.

Insider & Institutional Ownership

73.0% of Citigroup shares are held by institutional investors. Comparatively, 87.1% of Cigna shares are held by institutional investors. 0.1% of Citigroup shares are held by insiders. Comparatively, 0.9% of Cigna shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Citigroup and Cigna's top-line revenue, earnings per share (EPS) and valuation.

Citigroup has higher earnings, but lower revenue than Cigna. Cigna is trading at a lower price-to-earnings ratio than Citigroup, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Citigroup has a beta of 1.95, suggesting that its stock price is 95% more volatile than the S&P 500. Comparatively, Cigna has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500.

Summary

Cigna beats Citigroup on 11 of the 17 factors compared between the two stocks.

Morgan Stanley (NYSE:MS) and Cigna (NYSE:CI) are both large-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of current recommendations and price targets for Morgan Stanley and Cigna, as provided by MarketBeat.com.

Morgan Stanley presently has a consensus price target of $65.8571, indicating a potential downside of 18.56%. Cigna has a consensus price target of $248.40, indicating a potential upside of 7.71%. Given Cigna's stronger consensus rating and higher probable upside, analysts plainly believe Cigna is more favorable than Morgan Stanley.

Dividends

Morgan Stanley pays an annual dividend of $1.40 per share and has a dividend yield of 1.7%. Cigna pays an annual dividend of $0.04 per share and has a dividend yield of 0.0%. Morgan Stanley pays out 28.1% of its earnings in the form of a dividend. Cigna pays out 0.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Morgan Stanley has raised its dividend for 1 consecutive years and Cigna has raised its dividend for 1 consecutive years.

Insider & Institutional Ownership

76.8% of Morgan Stanley shares are held by institutional investors. Comparatively, 87.1% of Cigna shares are held by institutional investors. 0.3% of Morgan Stanley shares are held by insiders. Comparatively, 0.9% of Cigna shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Morgan Stanley and Cigna's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Morgan Stanley and Cigna's top-line revenue, earnings per share (EPS) and valuation.

Morgan Stanley has higher earnings, but lower revenue than Cigna. Cigna is trading at a lower price-to-earnings ratio than Morgan Stanley, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Morgan Stanley has a beta of 1.59, suggesting that its stock price is 59% more volatile than the S&P 500. Comparatively, Cigna has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500.

Summary

Cigna beats Morgan Stanley on 11 of the 17 factors compared between the two stocks.

Cigna (NYSE:CI) and Invesco QQQ Trust (NASDAQ:QQQ) are both large-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Analyst Ratings

This is a summary of current ratings and price targets for Cigna and Invesco QQQ Trust, as provided by MarketBeat.

Cigna presently has a consensus price target of $248.40, indicating a potential upside of 7.71%. Given Cigna's higher probable upside, analysts clearly believe Cigna is more favorable than Invesco QQQ Trust.

Dividends

Cigna pays an annual dividend of $0.04 per share and has a dividend yield of 0.0%. Invesco QQQ Trust pays an annual dividend of $1.74 per share and has a dividend yield of 0.6%. Cigna pays out 0.2% of its earnings in the form of a dividend. Cigna has raised its dividend for 1 consecutive years.

Insider & Institutional Ownership

87.1% of Cigna shares are owned by institutional investors. Comparatively, 47.0% of Invesco QQQ Trust shares are owned by institutional investors. 0.9% of Cigna shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Cigna and Invesco QQQ Trust's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Cigna and Invesco QQQ Trust's gross revenue, earnings per share (EPS) and valuation.

Cigna has higher revenue and earnings than Invesco QQQ Trust.

Risk and Volatility

Cigna has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, Invesco QQQ Trust has a beta of 1.05, meaning that its share price is 5% more volatile than the S&P 500.

Summary

Cigna beats Invesco QQQ Trust on 10 of the 13 factors compared between the two stocks.